DK1778655T3 - 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxy!-cyclohexylmethoxy}-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes - Google Patents
2-{-3-'2-(phenyl)-oxazol-4-ylmethoxy!-cyclohexylmethoxy}-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetesInfo
- Publication number
- DK1778655T3 DK1778655T3 DK05772240T DK05772240T DK1778655T3 DK 1778655 T3 DK1778655 T3 DK 1778655T3 DK 05772240 T DK05772240 T DK 05772240T DK 05772240 T DK05772240 T DK 05772240T DK 1778655 T3 DK1778655 T3 DK 1778655T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclohexylmethoxy
- ylmethoxy
- oxazol
- hyperlipidemia
- diabetes
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 2
- -1 2 - {- 3- [2- (phenyl) -oxazol-4-ylmethoxy] -cyclohexylmethoxy} -propionic acid derivatives Chemical class 0.000 title 1
- 208000031226 Hyperlipidaemia Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039532A DE102004039532B4 (de) | 2004-08-14 | 2004-08-14 | Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| PCT/EP2005/008281 WO2006018115A1 (de) | 2004-08-14 | 2005-07-30 | 2-{-3-`2 (phenyl) -oxazol-4 ylmethoxy!-cyclohexylmethoxy} - propionsäure derivate als ppar liganden (peroxisomen-proliferatoren-aktivierte rezeptoren) zur behandlung von hyperlipidämie und diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1778655T3 true DK1778655T3 (da) | 2009-08-24 |
Family
ID=35159900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05772240T DK1778655T3 (da) | 2004-08-14 | 2005-07-30 | 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxy!-cyclohexylmethoxy}-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7956077B2 (da) |
| EP (1) | EP1778655B1 (da) |
| JP (1) | JP2008509891A (da) |
| KR (1) | KR20070040813A (da) |
| CN (1) | CN101031553A (da) |
| AR (1) | AR050290A1 (da) |
| AT (1) | ATE430739T1 (da) |
| AU (1) | AU2005274492A1 (da) |
| BR (1) | BRPI0513999A (da) |
| CA (1) | CA2576545A1 (da) |
| DE (2) | DE102004039532B4 (da) |
| DK (1) | DK1778655T3 (da) |
| ES (1) | ES2326423T3 (da) |
| IL (1) | IL181010A0 (da) |
| MX (1) | MX2007000913A (da) |
| PE (1) | PE20060624A1 (da) |
| PT (1) | PT1778655E (da) |
| SV (1) | SV2006002191A (da) |
| TW (1) | TW200619211A (da) |
| UY (1) | UY29063A1 (da) |
| WO (1) | WO2006018115A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100915108B1 (ko) * | 2001-08-31 | 2009-09-03 | 사노피-아벤티스 도이칠란트 게엠베하 | Ｐｐａｒ-활성화제로서의 디아릴사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물 |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039532A patent/DE102004039532B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 AT AT05772240T patent/ATE430739T1/de not_active IP Right Cessation
- 2005-07-30 DK DK05772240T patent/DK1778655T3/da active
- 2005-07-30 BR BRPI0513999-6A patent/BRPI0513999A/pt not_active IP Right Cessation
- 2005-07-30 CN CNA2005800271498A patent/CN101031553A/zh active Pending
- 2005-07-30 KR KR1020077003581A patent/KR20070040813A/ko not_active Application Discontinuation
- 2005-07-30 MX MX2007000913A patent/MX2007000913A/es not_active Application Discontinuation
- 2005-07-30 WO PCT/EP2005/008281 patent/WO2006018115A1/de active Application Filing
- 2005-07-30 EP EP05772240A patent/EP1778655B1/de not_active Not-in-force
- 2005-07-30 JP JP2007525215A patent/JP2008509891A/ja not_active Abandoned
- 2005-07-30 AU AU2005274492A patent/AU2005274492A1/en not_active Abandoned
- 2005-07-30 DE DE502005007249T patent/DE502005007249D1/de active Active
- 2005-07-30 ES ES05772240T patent/ES2326423T3/es active Active
- 2005-07-30 CA CA002576545A patent/CA2576545A1/en not_active Abandoned
- 2005-07-30 PT PT05772240T patent/PT1778655E/pt unknown
- 2005-08-09 SV SV2005002191A patent/SV2006002191A/es unknown
- 2005-08-10 PE PE2005000924A patent/PE20060624A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127242A patent/TW200619211A/zh unknown
- 2005-08-11 AR ARP050103351A patent/AR050290A1/es not_active Application Discontinuation
- 2005-08-12 UY UY29063A patent/UY29063A1/es unknown
-
2007
- 2007-01-28 IL IL181010A patent/IL181010A0/en unknown
- 2007-02-06 US US11/671,673 patent/US7956077B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1778655B1 (de) | 2009-05-06 |
| US20070197613A1 (en) | 2007-08-23 |
| CA2576545A1 (en) | 2006-02-23 |
| BRPI0513999A (pt) | 2008-05-20 |
| ES2326423T3 (es) | 2009-10-09 |
| DE102004039532A1 (de) | 2006-03-02 |
| TW200619211A (en) | 2006-06-16 |
| DE102004039532B4 (de) | 2006-09-21 |
| MX2007000913A (es) | 2007-04-16 |
| DE502005007249D1 (de) | 2009-06-18 |
| EP1778655A1 (de) | 2007-05-02 |
| JP2008509891A (ja) | 2008-04-03 |
| CN101031553A (zh) | 2007-09-05 |
| WO2006018115A1 (de) | 2006-02-23 |
| SV2006002191A (es) | 2006-07-07 |
| AR050290A1 (es) | 2006-10-11 |
| KR20070040813A (ko) | 2007-04-17 |
| PT1778655E (pt) | 2009-07-13 |
| IL181010A0 (en) | 2007-07-04 |
| ATE430739T1 (de) | 2009-05-15 |
| AU2005274492A1 (en) | 2006-02-23 |
| PE20060624A1 (es) | 2006-07-27 |
| US7956077B2 (en) | 2011-06-07 |
| UY29063A1 (es) | 2006-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1789403T3 (da) | N-(phenyl-oxazol-4ylmethoxymethyl)-cyclohexyl-ravsyreamid derivater og beslægtede forbindelser som PPAR-ligander (peroxisom-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes | |
| NO20054396D0 (no) | 3-metyl-2-(3-(2-fenyl-oksazol-4-ylmetoksy)-cykloheksankarbonyl-amino)-smorsyrederivater og lignende forbindelser som PPAR-modulatorer til behandling av type 2 diabetes og aterosklerose | |
| DK1651622T3 (da) | Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser | |
| DK1349843T3 (da) | Thiazol- og oxazolderivater som aktivatorer af human peroxisom profilerator-aktiverede receptorer | |
| ATE405260T1 (de) | Thiazol- und oxazolderivaten als ppar modulatoren | |
| DK1678185T3 (da) | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose | |
| DK1458672T3 (da) | Substituerede phenylpropionsyrederivater som antagonister af human peroxisomproliferatoraktiveret receptor alfa (PPAR) | |
| DK2059513T3 (da) | Fremgangsmåde til fremstillingen af 1,2,4-oxadiazolbenzoesyrer | |
| IL175310A0 (en) | Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists | |
| JP2008506643A5 (ja) | 糖尿病の治療用の血糖値低下活性成分として使用するためのホスホチロシン・ホスファターゼ１ｂ(ｐｔｐ１ｂ)阻害剤としてのジフェニルアミン置換サリチルチアゾール誘導体及び関連化合物 | |
| SG130141A1 (en) | Modulation of peroxisome proliferator-activated receptors | |
| DK1539746T3 (da) | N-substituerede 1H-indol-5-propionsyre-forbindelser som PPAR-agonister der er nyttige til behandling af diabetes | |
| ATE525355T1 (de) | 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1 | |
| DK2300452T3 (da) | 5 -[5- [2-(3,5 -(bis(trifluoromethyl)phenyl) -2 - methylpropanoylmethylamino ]-4 -(4-fluoro -2-methylphenyl)]-2-pyridinyl -2-alkyl -prolinamid som NK1 receptor antagonister | |
| WO2008043024A3 (en) | Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease | |
| DK1778655T3 (da) | 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxy!-cyclohexylmethoxy}-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes | |
| SG138604A1 (en) | Modulation of peroxisome proliferator-activated receptors | |
| DK1789402T3 (da) | 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy)-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes | |
| DK1399430T3 (da) | Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren | |
| DK1517883T3 (da) | Ortho-substituerede benzoesyrederivater til behandling af insulinresistens | |
| DK1517679T3 (da) | Ortosubstituerede benzoesyrederivater til behandling af insulinresistens | |
| FI20045034A0 (fi) | Laite pienpuun keräämiseksi |